Recently, compound heterozygosity for rare damaging variants in MYH6 or MYBPC3, encoding myosin binding protein C3, was found to be a risk factor for myocardial dysfunction in patients with HLHS [58]. The gene discussed is MYBPC3; the disease is hypoplastic left heart syndrome.